HomeAI · summaries
Storia in 2 fonti
This Aggressive Prostate Cancer Finally Has Targeted Treatment — AstraZeneca Wins FDA Nod - AstraZeneca (
Major FDA wins for AstraZeneca: Truqap combination approved for advanced prostate cancer; Ultomiris kidney disease drug gets Priority Review.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
TRUQAP® (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive…
TRUQAP® (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer
- ·
benzinga.com
This Aggressive Prostate Cancer Finally Has Targeted Treatment — AstraZeneca Wins FDA Nod - AstraZeneca (
Major FDA wins for AstraZeneca: Truqap combination approved for advanced prostate cancer; Ultomiris kidney disease drug gets Priority Review.